Consolidated Statement of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Revenue	$ 383,936	$ 303,956	$ 242,667
Veterinary invoice expense	270,947	214,539	170,122
Other Cost of Services Sold	48,065	38,051	29,495
Gross profit	64,924	51,366	43,050
Technology and Development Expense	10,074	9,248	9,768
General and administrative	20,967	18,164	16,820
Sales and marketing	35,451	24,999	19,104
Total operating expenses	66,492	52,411	45,692
Income (Loss) from Equity Method Investments	(352)	0	0
Operating loss	(1,920)	(1,045)	(2,642)
Interest expense	1,349	1,198	533
Other income, net	(1,629)	(1,309)	(1,244)
Loss before income taxes	(1,640)	(934)	(1,931)
Income tax (benefit) expense	169	(7)	(428)
Net loss	$ (1,809)	$ (927)	$ (1,503)
Earnings Per Share, Basic and Diluted	$ (0.05)	$ (0.03)	$ (0.05)
Weighted Average Number of Shares Outstanding, Basic and Diluted	34,645,345	31,961,192	29,588,324